Human nerve growth factor

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530/13, 530/3.18

C07K 14/48 (2006.01) C07K 1/36 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1339791

A process is disclosed for the preparation of a biologically active subunit ( .beta. subunit) of human nerve growth factor (NGF) from human placenta. The process involves homogenizing the tissue of human placenta, dialysing the homogenized tissue at pH 4.0 in order to dissociate the 7S NGF form, and chromatographically fractionating the resultant solution on a three step cation exchange chromatography column. The active fraction can be purified by cation exchange chromatography or affinity chromatography on polyclonal antibodies. Pharmaceutical compositions containing the active subunit are also disclosed.

593792

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human nerve growth factor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human nerve growth factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human nerve growth factor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1254698

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.